Safe & Secure Cities theme takes centre stage at Municipalika 2026
NEW DELHI, Dec. 24, 2025 /PRNewswire/ -- Municipalika, India's leading platform for…
TV Rheinland Reinforces Global Contamination Control with Clean Room Validation Services
Comprehensive Testing, Independent Verification and International Compliance Support for High-Precision and Regulated…
Cambridge Mobile Telematics Receives Frost & Sullivan’s 2025 Global Telematics Insurance and Connected Claims Market Leadership Recognition for Excellence in Mobility Ecosystem Innovation
CMT is honored for advancing crash technology and shaping the future of…
Menarini Group Presents Elacestrant (ORSERDU) Phase 2 Combination Data in Patients with ER+, HER2- Metastatic Breast Cancer (mBC) at the 2025 San Antonio Breast Cancer Symposium
In addition, the expansive elacestrant clinical development program updates reinforce its potential as…
TraceLink Supports UNICEF’s Traceability and Verification System (TRVST) to Advance Safe, Authentic Medicine Access Globally
TraceLink announced its support for UNICEF's Traceability and Verification System (TRVST), a…
Tenant and Domestic Help Verification Emerges as a Vital Safety Practice Across Indian Families, Landlords and Brokers
Verification has become an important conversation across Indian cities as more households,…
Mercedes star shines bright as Euro NCAPs final results deliver safer options for every buyer
LEUVEN, BELGIUM – Euro NCAP’s independent assessment of the new CLA shows…
Kia PV5 Cargo Achieves Maximum FiveStar Rating in 2025 Euro NCAP Commercial Van Safety Assessment
Kia PV5 Cargo earns the top five-star rating in the 2025 Euro…
ASH 2025 | Updated Data for Ascentage Pharmas Olverembatinib in Second-Line CML-CP Showing Encouraging Potential for Early-Line Treatment
76.7% complete cytogenetic response rate achieved in patients who failed second-generation TKI…
UCB presents positive results from GEMZ phase 3 study at AES showing fenfluramine significantly reduces countable motor seizure frequency in CDKL5 Deficiency Disorder
Seizure reduction: phase 3 study achieved primary endpoint as fenfluramine demonstrated a…